bioAffinity Technologies, Inc. (BIAFW) shareholders
BIAFWNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31Also trades as BIAF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 4/3056% below fair value
$0.24+0.00 (0.00%)
Close on Oct 30, 2026Market cap $23.58MP/E –Yield –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
0M
Shares held, 13F filers
Institutional holders
4
0 new, 0 sold out
Net institutional buying
-0M
In Q2 2026
Insider trades, 12 months
0 buys · 0 sales
Open-market trades only
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Richard K. Crumly | 3,213,777 | 11.20% | 13G (passive) | May 7, 2025 |
| Bigger Michael | 117,364 | 5.79% | 13G (passive) | Sep 29, 2025 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of BIAFW | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Clear Street Group Inc. | 54,927 | – | $7.66K | – | 0.00% |
| UBS Group AG | 46,445 | – | $6.50K | +336 | 0.00% |
| Citadel Advisors LLC | 17,162 | – | $2.39K | −2,688 | 0.00% |
| Susquehanna International Group, Llp | 11,180 | – | $1.55K | +167 | 0.00% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|
| Q2 2026 | 4 | 0M | 0 / 2 | 1 / 0 | 0M | 0M |
| Q1 2026 | 4 | 0M | 1 / 0 | 3 / 0 | 0M | 0M |
| Q4 2025 | 3 | 0M | 0 / 0 | 3 / 0 | 0M | 0M |
| Q3 2025 | 3 | 0M | 1 / 2 | 0 / 1 | 0M | 0M |
| Q2 2025 | 4 | 0M | 0 / 1 | 1 / 0 | 0M | 0M |
| Q1 2025 | 4 | 0M | 0 / 1 | 2 / 1 | 0M | 0M |
| Q4 2024 | 5 | 0M | 1 / 3 | 0 / 0 | 0M | 0M |
| Q3 2024 | 4 | 0M | 1 / 1 | 1 / 1 | 0M | 0M |
| Q2 2024 | 4 | 0M | 0 / 1 | 2 / 0 | 0M | 0M |
| Q1 2024 | 4 | 0M | 0 / 1 | 2 / 0 | 0M | 0M |
| Q4 2023 | 4 | 0M | 0 / 0 | 1 / 1 | 0M | 0M |
| Q3 2023 | 5 | 0M | 1 / 1 | 2 / 1 | 0M | 0M |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | Latest filing |
|---|---|---|---|
| Steven Girgenti | Executive Chairman, Director | 1,089,017 | Jan 14, 2025 |
| Maria Zannes | President & CEO, Director | 280,359 | Jan 14, 2025 |
| Xavier Trinidad Reveles | Chief Operating Officer | 41,943 | Jan 14, 2025 |
| Timothy P. Zannes | Secretary, EVP, Gen. Counsel | 54,765 | Jan 14, 2025 |
| James Michael Edwards | VP and CFO | 120,128 | Jan 14, 2025 |
| John J. Oppenheimer | Director | – | Sep 25, 2025 |
| Roberto Rios | Director | 833 | Sep 25, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Xavier Trinidad Reveles Chief Operating Officer | Jan 10, 2025 | Award | +21,604 | – | – | 41,943 |
| Maria Zannes President & CEO, Director | Jan 10, 2025 | Award | +37,037 | – | – | 280,359 |
| James Michael Edwards VP and CFO | Jan 10, 2025 | Award | +6,172 | – | – | 120,128 |
| Steven Girgenti Executive Chairman, Director | Jan 10, 2025 | Award | +14,814 | – | – | 1,080,062 |
| Timothy P. Zannes Secretary, EVP, Gen. Counsel | Jan 10, 2025 | Award | +8,641 | – | – | 54,765 |
| James Michael Edwards VP and CFO | Nov 5, 2024 | Award | +100,000 | – | – | 113,956 |
| Roby Joyce Director | Jul 1, 2024 | Award | +33,784 | – | – | 66,615 |
| Steven Girgenti Executive Chairman, Director | Jul 1, 2024 | Award | +33,784 | – | – | 1,065,248 |
| Robert A. Anderson Director | Jul 1, 2024 | Award | +33,784 | – | – | 163,936 |
| Stuart Diamond Director | Jul 1, 2024 | Award | +33,784 | – | – | 99,088 |
| Gary D. Rubin Director, 10% owner | Jul 1, 2024 | Award | +33,784 | – | – | 146,597 |
| Jamie Platt Director | Jul 1, 2024 | Award | +33,784 | – | – | 54,748 |
| Peter S. Knight Director | Jul 1, 2024 | Award | +33,784 | – | – | 117,455 |
| Maria Zannes President & CEO, Director | Jul 1, 2024 | Award | +33,784 | – | – | 243,322 |
| Robert A. Anderson Director | Jun 12, 2024 | Award | +8,296 | – | – | 130,152 |
| Roby Joyce Director | Jun 12, 2024 | Award | +8,296 | – | – | 32,831 |
| Stuart Diamond Director | Jun 12, 2024 | Award | +8,296 | – | – | 65,304 |
| Jamie Platt Director | Jun 12, 2024 | Award | +8,296 | – | – | 20,964 |
| Sandler Revocable Trust Harvey 10% owner | Jun 12, 2024 | Award | +8,296 | – | – | 112,813 |
| Peter S. Knight Director | Jun 12, 2024 | Award | +8,296 | – | – | 83,671 |
| Steven Girgenti Executive Chairman, Director | Jun 12, 2024 | Award | +8,296 | – | – | 1,031,464 |
| Maria Zannes President & CEO, Director | Jun 12, 2024 | Award | +8,296 | – | – | 209,538 |
| Maria Zannes President & CEO | Apr 8, 2024 | Option exercise | +64,848 | $1.16 | $75.22K | 229,506 |
| Maria Zannes President & CEO | Apr 8, 2024 | Tax withholding | −28,264 | $2.65 | $74.90K | 201,242 |
| Timothy P. Zannes Secretary, EVP, Gen. Counsel | Apr 4, 2024 | Option exercise | +64,848 | $1.16 | $75.22K | 75,155 |
| Timothy P. Zannes Secretary, EVP, Gen. Counsel | Apr 4, 2024 | Tax withholding | −29,031 | $2.58 | $74.90K | 46,124 |
| Steven Girgenti Director | Apr 3, 2024 | Tax withholding | −33,438 | $2.24 | $74.90K | 1,023,168 |
| Steven Girgenti Director | Apr 3, 2024 | Option exercise | +64,848 | $1.16 | $75.22K | 1,056,606 |
| Robert A. Anderson Director | Feb 26, 2024 | Option exercise | +64,848 | $1.16 | $75.22K | 121,856 |
| Steven Girgenti Executive Chairman, Director | Feb 16, 2024 | Award | +39,474 | $1.52 | $60.00K | 991,758 |
| Michael Philip Dougherty Chief Financial Officer | Jan 31, 2024 | Award | +31,847 | – | – | 84,203 |
| Vivienne I. Rebel Chief Sci. & Med. Officer, EVP | Jan 31, 2024 | Award | +31,847 | – | – | 46,228 |
| Timothy P. Zannes Secretary, EVP, Gen. Counsel | Jan 31, 2024 | Award | +6,688 | – | – | 10,307 |
| Xavier Trinidad Reveles Chief Operating Officer | Jan 31, 2024 | Award | +16,720 | – | – | 20,339 |
| Maria Zannes President, CEO, Director | Jan 31, 2024 | Award | +23,885 | – | – | 164,658 |
| Steven Girgenti Executive Chairman, Director | Jan 31, 2024 | Award | +11,943 | – | – | 952,284 |
| Gary D. Rubin Director, 10% owner | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 104,517 |
| Steven Girgenti Executive Chairman, Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 940,341 |
| Robert A. Anderson Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 57,008 |
| Peter S. Knight Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 75,375 |
| Maria Zannes President, CEO, Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 140,773 |
| Stuart Diamond Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 57,008 |
| Living Trust Joyce – | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 24,535 |
| Jamie Platt Director | Jan 1, 2024 | Award | +12,668 | $1.48 | $18.75K | 12,668 |
| Gary D. Rubin Director, 10% owner | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 91,849 |
| Steven Girgenti Executive Chairman, Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 927,673 |
| Robert A. Anderson Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 44,340 |
| Peter S. Knight Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 62,707 |
| Mohsin Y. Meghji Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 109,737 |
| Maria Zannes President, CEO, Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 128,105 |
| Stuart Diamond Director | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 44,340 |
| Living Trust Joyce – | Oct 1, 2023 | Award | +11,867 | $1.58 | $18.75K | 11,867 |
| Steven Girgenti Executive Chairman, Director | Aug 9, 2023 | Award | +26,315 | $2.28 | $60.00K | 915,806 |
| Steven Girgenti Executive Chairman, Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 889,491 |
| Stuart Diamond Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 32,473 |
| Robert A. Anderson Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 32,473 |
| Mohsin Y. Meghji Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 97,870 |
| Peter S. Knight Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 50,840 |
| Maria Zannes President, CEO, Director | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 116,238 |
| Sandler Revocable Trust Harvey 10% owner | Jul 1, 2023 | Award | +10,245 | $1.83 | $18.75K | 79,982 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 15, 2026 (FINRA, reported twice a month)
Short % of shares outstanding
–
0M shares short
Days to cover
1.1
At 0M shares a day
Change since last report
-31.0%
From 0M shares
Short volume, 20 days
7.3%
Of volume reported to FINRA
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of bioAffinity Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 4,936 shares on Sep 4, 2026 over the last 90 days.